Robert E. Bancroft
CIK: 0002066370
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AEON
AEON Biopharma, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Bancroft Robert E.
Bancroft Robert E. (SEC CIK 0002066370) files insider reports with the SEC as PRESIDENT & CEO of AEON Biopharma, Inc. (AEON).
Signal8 holds 4 ownership filings by Bancroft Robert E. (1 Form 3, 3 Form 4), filed between May 1, 2025 and Feb 19, 2026. Those filings report 3 transactions, from Apr 29, 2025 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bancroft Robert E.'s filings is in IRVINE, CA.
Recent filings by Bancroft Robert E.
Other insiders filing for AEON Biopharma, Inc. (AEON)
- LYNCH TIMOTHY P, 10% Owner
- Thunen Shelley B, Director
- PALMISANO ROBERT J, Director
- Forth Marc, Director
- FISCHER JOST, Director
- Carter Eric G, Director